Aemetis Inc expected to post a loss of 41 cents a share - Earnings Preview

Reuters
03-03
<a href="https://laohu8.com/S/AMTX">Aemetis Inc</a> <amtx.oq> expected to post a loss of 41 cents a share - Earnings Preview </amtx.oq>
  • Aemetis Inc AMTX.OQ AMTX.O is expected to show a rise in quarterly revenue when it reports results on March 5 (estimated) for the period ending December 31 2024

  • The Cupertino California-based company is expected to report a 9.6% increase in revenue to $77.55 million from $70.76 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Aemetis Inc is for a loss of 41 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Aemetis Inc is $6.75​, above​ its last closing price of $1.80. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.44

-0.42

-0.38

Beat

9.7

Jun. 30 2024

-0.42

-0.43

-0.66

Missed

-52.1

Mar. 31 2024

-0.43

-0.46

-0.58

Missed

-27.4​

Dec. 31 2023

-0.30

-0.34

-0.64

Missed

-88.5

​​Sep. 30 2023

-0.31

-0.29

0.73

Beat

353

Jun. 30 2023

-0.36

-0.39

-0.68

Missed

-73​

Mar. 31 2023

-0.47

-0.39

-0.73

Missed

-88.4

Dec. 31 2022

-0.26

-0.27

-0.63

Missed

-135.5

This summary was machine generated March 3 at 13:42 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10